ABSTRACT Nonsyndromic cleft lip with or without cleft palate is a common congenital deformity worldwide with multifaceted etiology. Interaction of genes and environmental factors has been indicated to be related with susceptibility to nonsyndromic cleft lip with or without cleft palate. Some WNT genes which are involved in craniofacial embryogenesis may play a key role in the pathogenesis of nonsyndromic cleft lip with or without cleft palate. In the present study, we aimed to inspect the relationship between WNT3 (rs3809857 and rs9890413), WNT3A (rs752107 and rs3121310), and WNT10a rs201002930 (c.392 C>T) polymorphisms and nonsyndromic cleft lip with or without cleft palate in an Iranian population. The present casecontrol study was carried out on 120 unrelated nonsyndromic cleft lip with or without cleft palate patients and 112 healthy subjects. The variants were genotyped by polymerase chain reaction-restriction fragment length polymorphism method. The findings suggest that the rs3809857 polymorphism significantly decreased the risk of nonsyndromic cleft lip with or without cleft palate in codominant (odds ratio = 0.16, 95% confidence interval = 0.03-0.75, P = 0.020, TT vs GG), recessive (odds ratio = 0.16, 95% confidence interval = 0.03-0.72, P = 0.009, TT vs GG + GT) inheritance models. The rs9890413 variant marginally decreased the risk of nonsyndromic cleft lip with or without cleft palate in codominant (odds ratio = 0.41, 95% confidence interval = 0.17-0.99, P = 0.047, AG vs AA) model. Regarding C392T variant, the findings revealed that this variant significantly decreased the risk of nonsyndromic cleft lip with or without cleft palate in codominant (odds ratio = 0.24, 95% confidence interval = 0.10-0.58, P = 0.002, CT vs CC) and allele (odds ratio = 0.26, 95% confidence interval = 0.11-0.62, P = 0.002, T vs C) models. No significant association was observed between the rs752107 and rs3121310 variants and risk/ protection of nonsyndromic cleft lip with or without cleft palate. Stratified analysis showed that WNT10a rs201002930 (c.392 C>T) significantly decreased the risk of cleft lip with cleft palate and cleft palate only. In summary, the results suggest an association between WNT genes polymorphisms and the risk nonsyndromic cleft lip with or without cleft palate in a sample of the southeast Iranian population.
INTRODUCTION
Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common congenital anomaly among live births worldwide (Dixon et al. 2011) . The average incidence of NSCL/P is approximately 1.7 per 1000 live births, although this rate is different in terms of geographical location and ethnicity (Mossey et al. 2009 ).
Although, the precise etiology of NSCL/P is unknown, it is proposed that genetic and environmental factors play essential role in the etiology of the disease (Dixon et al. 2011) . Genetic variants in FGF1 rs34010, CDH1 rs16260, MSX1 rs12532, DHFR 19 bp indel, and BMP4 rs17563 genes are shown to be associated with the risk of NSCL/P in an Iranian population (Rafighdoost et al. 2013 (Rafighdoost et al. , 2015 (Rafighdoost et al. , 2017 Rafiqdoost et al. 2014) .
The WNT genes consist of structurally related genes encoding a large family of secreted signaling glycoprotein that have been involved in oncogenesis and in numerous developmental processes, such as regulation of cell fate and patterning during embryogenesis (Logan and Nusse 2004; Nusse 2008) . WNT3, WNT3A, and WNT10A genes mapped to 17q21.31-q21.32, 1q42.13, and 2q35, respectively (Roelink et al. 1993; Kirikoshi et al. 2001; Saitoh et al. 2001) . Wnts, a family of secreted signaling molecules, play crucial roles in diverse aspects of craniofacial development (Mani et al. 2010; Cawthorn et al. 2012) . WNT genes have been proposed as candidate genes for NSCL/P, due to their essential functions during embryonic development (Yamaguchi et al. 1999; Chiquet et al. 2008) . Regarding research on the association between genetic polymorphisms of WNT genes and NSCL/P susceptibility, Chiquet et al. (2008) studied the relationship between the genetic polymorphisms of WNT genes and the risk of developing NSCL/P. Their results showed that WNT3A, WNT11, and WNT8A were significantly associated with NSCL/P. Menezes et al. (2010) have found that WNT3 rs142167 and rs9890413 polymorphisms significantly increased the risk of NSCL/P. Mostowska et al. (2012) findings revealed that WNT3 rs3809857 variant significantly decreased the risk of NSCL/P. Lu et al. (2015) have found an association between WNT3 rs3809857 and rs9890413 polymorphisms and NSCL/P. They reported that rs3809857 variant significantly decreased and rs9890413 variant significantly increased the risk of NSCL/P. Feng et al. (2014) have found that WNT10a rs201002930 (c.392 C>T) variant significantly increased the risk of NSCL/P.
Currently, to the best of our knowledge, there is no study on the association between the WNT gene polymorphisms and the risk of developing NSCL/P in Iranian population. Accordingly, repeating previously described genetic associations in different populations is required to define the associations of the genetic risk in each population. Using a case-control design method, the present study aimed to evaluate the possible association between WNT3 (rs3809857 and rs9890413), WNT3A (rs752107 and rs3121310), and WNT10a rs201002930 (c.392 C>T) polymorphisms and NSCL/P risk in a sample of southeast Iranian population.
MATERIALS AND METHODS
A total of 232 subjects including 120 NSCL/P and 112 healthy subjects were recruited in this case-control study. Ethical approval was obtained from ethical committee of Zahedan University of Medical Sciences (IR.ZAUMS.REC.1395.62). The criteria for participants with NSCL/P and healthy individuals were described elsewhere previously (Rafighdoost et al. 2013 (Rafighdoost et al. , 2015 (Rafighdoost et al. , 2017 Rafiqdoost et al. 2014) . The controls without the family history of NSCL/P were matched to cases for age, sex, and ethnic background. Blood samples were collected in EDTA-containing tubes and genomic DNA was extracted by salting-out method.
Genotyping
Genotyping of the variants was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism method. The primer sequences, annealing temperature, restriction enzymes, and amplicon sizes are shown in Table 1 . PCR was performed using Prime Taq premix (Genetbio, Daejeon, South Korea) according to the manufacturer's procedure. Each 0.20 mL PCR tube contained 1 μL of genomic DNA (~100 ng/μL), 1 μL of each primer (10 μM), 10 μL of 2X Prime Taq Premix and 7 μL of ddH2O. The PCR conditions included an initial denaturation at 95 C for 5 min, followed by 30 cycles for 30 s at 95 C and annealing temperature (Table 1) for 30 s, extension at 72 C for 30 s, with a final extension of 72 C for 10 min. The PCR products (10 μL) were digested by suitable restriction enzymes (Table 1 ) and the digested products were resolved by agarose gel electrophoresis and visualized on a UV transilluminator. To confirm the genotyping quality for each polymorphism, approximately 20% of randomly selected samples were regenotyped and the results confirmed the preceding genotyping findings.
Statistical analysis
All statistical analyses were carried using the SPSS 22.0 software (IBM Corp., Armonk, NY,USA). Independent sample t-test and chi-square test were used for continuous and categorical data, respectively. The associations between alleles or genotypes and NSCL/P were evaluated by calculating the odds ratio (OR) and 95% confidence intervals (95% CIs) from unconditional logistic regression analyses. P-value of <0.05 was considered statistically significant.
RESULTS
This study consisted of 120 NSCL/P (78 males and 42 females, age: 12.65 AE 9.98 years) and 112 healthy subjects (68 males and 44 females, age: 11.43 AE 11.86 years). There were no statistically significant differences between the groups regarding sex and age (P = 0.499 and P = 0.398, respectively). Of the 120 patients, 38 had cleft lip only (CL), 48 had CL with CP (CLP), and 34 had cleft palate only (CP). Excluding 21 patients for whom the family history of clefts was unidentified, 46.5% of the patients stated to have positive family history of clefts.
Genotypic and allelic frequencies of WNT gene polymorphisms are shown in Table 2 . Our findings showed that rs3809857 polymorphism significantly decreased the risk of NSCL/P in codominant (OR = 0.16, 95% CI = 0.03-0.75, P = 0.020, TT vs GG), and recessive (OR = 0.16, 95% CI = 0.03-0.72, P = 0.009, TT vs GG + GT) inheritance models. Regarding rs9890413 variant, the findings revealed that rs9890413 variant marginally decreased the risk of NSCL/P in codominant (OR = 0.41, 95% CI = 0.17-0.99, P = 0.047, AG vs AA) model. Concerning C392T variant, the results proposed that this variant significantly decreased the risk of NSCL/P in codominant (OR = 0.24, 95% CI = 0.10-0.58, P = 0.002, CT vs CC) and allele (OR = 0.26, 95% CI = 0.11-0.62, P = 0.002, T vs C) models. The rs752107 and rs3121310 variants were not associated with the risk/protection of NSCL/P.
We performed subphenotyping of clefts and the patients were divided into the CL, CLP, and CP (Table 3) . Our findings suggested CT genotype as well as T allele of rs201002930 variant significantly decreased the risk of CLP and CP. DISCUSSION NSCL/P is well known to be influenced by genetic and environmental factors. The WNT genes encode a large family of secreted glycoproteins that are involved in appropriate midface development and upper lip fusion (Logan and Nusse 2004; Nusse 2008 
OR ( © 2018 Japanese Teratology Society discrete intracellular signaling pathways which are categorized as canonical and noncanonical Wnt pathways (Nelson and Nusse 2004) . Single nucleotide polymorphisms (SNPs), the most abundant form of genetic variations in the human genome, contribute to phenotypic differences in and among populations. Exonic SNPs have a direct effect on the properties of proteins, whereas SNPs within introns and untranslated region (3 0 UTR and 5 0 UTR) can affect the expression and splicing of mRNA (Cai et al. 2015; Narouie et al. 2017; Hashemi et al. 2018) . Only a few genetic association studies have been carried out regarding the impact of WNT gene polymorphisms on the risk of NSCL/P (Chiquet et al. 2008; Menezes et al. 2010; Yao et al. 2011; Mostowska et al. 2012; Feng et al. 2014; Lu et al. 2015 ). In the current study, we examined the possible association between WNT polymorphisms and the risk of NSCL/P. Our findings revealed a significant association between rs3809857, rs9890413, and C392T polymorphisms and protection against NSCL/P. In addition, stratified analysis revealed that C392T variant was associated with decreased the risk of CLP as well as CP.
It has been proposed that Wnt3A which controls the fate of both mesenchymal cells and neural crest cells in the craniofacial processes may play a role in the pathogenesis of NSCL/P (Yamaguchi et al. 1999) . Chiquet et al. (2008) have found that WNT3A, WNT11, and WNT8A were significantly associated with NSCL/P in American population. Yao et al. (2011) reported that 752107 and rs3121310 variants of WNT3A were significantly associated with the risk of NSCL/P. Menezes et al. (2010) evaluated the possible association between 13 SNPs located in WNT3A, WNT5A, WNT8A, WNT11, WNT3, and WNT9B genes and NSCL/P. They found that WNT3 rs142167 and rs9890413 polymorphisms significantly increased the risk of predisposition to NSCL/P. Lu et al. (2015) investigated the impact of WNT3 rs3809857 and rs9890413 polymorphisms on the risk of NSCL/P. In agreement to our findings, they found that rs3809857 variant significantly decreased the risk of NSCL/P. However, in contrast to our findings, they reported that rs9890413 significantly increased the risk of NSCL/P. Mostowska et al. (2012) studied the possible association between 14 polymorphisms in WNT3, WNT3A, WNT5A, WNT8A, WNT9B, and WNT11 genes and risk of NSCL/P. They observed that WNT3 rs3809857 variant significantly decreased the risk of NSCL/P. Feng et al. (2014) have found an association between c.392 C>T variant and risk of NSCL/P so that CT + TT genotype as well as T allele significantly increased the risk of NSCL/P.
The controversial findings may be due to different ethnic origins, environmental differences, and the complex genetic etiology of NSCL/P disease. One of the limitations of the current study is relatively small sample size. Another limitation is that we assessed limited polymorphisms of the WNT genes; the other genetic variations should be estimated.
In conclusion, our findings support the involvement of genetic variants of WNT genes in the development of NSCL/P. Further studies with larger samples from different ethnicities are needed to certify our findings.
